30 Best Stocks To Invest In According to Billionaires

Page 19 of 29

11. Eli Lilly and Company (NYSE:LLY)

No. of Billionaire Investors: 23

Total Value of Billionaire Holdings: $13.74 Billion

Eli Lilly and Company (NYSE:LLY) is a leading American multinational pharmaceutical company, with a global presence in 18 countries. Its products are distributed in approximately 125 countries, showing its global reach. Eli Lilly and Company aims to pioneer pharmaceutical advancements, as well as focuses on inclusive clinical trials and is committed to ensuring its medicines are both accessible and affordable for diverse populations.

On February 3, Truist Securities analyst Srikripa Devarakonda increased the price target on LLY shares from $1,029 to $1,038 per share, maintaining a Buy rating on the shares. Devarakonda is optimistic regarding the company’s future on the back of strong Q4 and full-year 2024 results. The company posted Q4 revenue of $13.53 billion, surging 45% year-over-year, and full-year revenue increased 32% compared to 2023. The strong growth was driven by the increased sales volume of Mounjaro and Zepbound. The company’s quarterly earnings per share more than doubled, rising 114% to $5.32 per share.

Eli Lilly and Company (NYSE:LLY) stays on the growth trajectory and projects 2025 revenue between $58 billion and $61 billion, reflecting a 32% year-over-year increase. LLY estimates EPS in the range of $22.05 to $23.55, reinforcing confidence in its financial trajectory and continued innovation.

Page 19 of 29